These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Etretinate. Appropriate use in severe psoriasis. Lowe NJ; Roenigk H; Voorhees JJ Arch Dermatol; 1988 Apr; 124(4):527-8. PubMed ID: 3281595 [No Abstract] [Full Text] [Related]
26. Methotrexate and etretinate in the treatment of psoriasis. Vanderveen EE; Ellis CN Arch Dermatol; 1984 Dec; 120(12):1555-6. PubMed ID: 6508327 [No Abstract] [Full Text] [Related]
27. Etretinate in pustular psoriasis of palms and soles. White SI; Marks JM; Shuster S Br J Dermatol; 1985 Nov; 113(5):581-5. PubMed ID: 3904810 [TBL] [Abstract][Full Text] [Related]
28. Etretinate (Tigason) hepatitis in 2 patients. van Voorst Vader PC; Houthoff HJ; Eggink HF; Gips CH Dermatologica; 1984; 168(1):41-6. PubMed ID: 6698264 [TBL] [Abstract][Full Text] [Related]
29. [Curling and kinking of hair caused by etretinate]. Schauder S; Tsambaos D; Nikiforidis G Hautarzt; 1992 Aug; 43(8):509-13. PubMed ID: 1506218 [TBL] [Abstract][Full Text] [Related]
30. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis]. Gajardo J Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162 [TBL] [Abstract][Full Text] [Related]
31. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis. White SI; Puttick L; Marks JM Br J Dermatol; 1986 Nov; 115(5):577-82. PubMed ID: 3539171 [TBL] [Abstract][Full Text] [Related]
32. [Skeletal alterations associated with long-term etretinate therapy]. Okada N; Higashiyama M; Morimoto S; Yoshikawa K Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):547-52. PubMed ID: 1890751 [TBL] [Abstract][Full Text] [Related]
33. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)]. Bordier C; Flechet ML; Thomine E; Lauret P Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213 [No Abstract] [Full Text] [Related]
34. Serial liver biopsies in psoriatic patients receiving long-term etretinate. Roenigk HH; Gibstine C; Glazer S; Sparberg M; Yokoo H Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836 [TBL] [Abstract][Full Text] [Related]
35. Cystic acne in psoriatic patients undergoing etretinate therapy. Menter A; Boyd A J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):751-2. PubMed ID: 2967312 [No Abstract] [Full Text] [Related]
36. Hepatotoxic reactions in a patient treated with etretinate. Weiss VC; West DP; Ackerman R; Robinson LA Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707 [TBL] [Abstract][Full Text] [Related]
37. [Etretinate in familial pustular psoriasis]. Schewach-Millet M; Shifer O; Ziv R Harefuah; 1986 Sep; 111(5-6):112-3. PubMed ID: 3804054 [No Abstract] [Full Text] [Related]
38. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis. Glazer SD; Roenigk HH; Yokoo H; Sparberg M J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):683-7. PubMed ID: 7068976 [TBL] [Abstract][Full Text] [Related]
39. Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis. Thirumoorthy T; Tham SN; Tan YC J Dermatol; 1986 Apr; 13(2):132-6. PubMed ID: 3531270 [No Abstract] [Full Text] [Related]